0001209191-17-044235.txt : 20170706
0001209191-17-044235.hdr.sgml : 20170706
20170706191341
ACCESSION NUMBER: 0001209191-17-044235
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170703
FILED AS OF DATE: 20170706
DATE AS OF CHANGE: 20170706
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADURO BIOTECH, INC.
CENTRAL INDEX KEY: 0001435049
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 740 HEINZ AVENUE
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 510-848-4400
MAIL ADDRESS:
STREET 1: 740 HEINZ AVENUE
CITY: BERKELEY
STATE: CA
ZIP: 94710
FORMER COMPANY:
FORMER CONFORMED NAME: ADURO BIOTECH
DATE OF NAME CHANGE: 20080514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lew Jennifer
CENTRAL INDEX KEY: 0001465994
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37345
FILM NUMBER: 17953595
MAIL ADDRESS:
STREET 1: 2929 SEVENTH STREET, SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-03
0
0001435049
ADURO BIOTECH, INC.
ADRO
0001465994
Lew Jennifer
C/O ADURO BIOTECH, INC.
740 HEINZ AVENUE
BERKELEY
CA
94710
0
1
0
0
Sr. Vice President of Finance
Common Stock
2017-07-03
4
M
0
12000
0.82
A
54595
D
Common Stock
2017-07-03
4
S
0
12000
11.136
D
42595
D
Stock Option (Right to Buy)
0.82
2017-07-03
4
M
0
12000
0.00
D
2023-11-26
Common Stock
12000
83709
D
The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.85 to $11.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Twenty-five percent of the shares subject to the Option vested on the first anniversary of the vesting commencement date of October 25, 2014, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
/s/ Jennifer Lew
2017-07-06